Literature DB >> 26880698

Effects of lipopolysaccharide, multiwalled carbon nantoubes, and the combination on lung alveolar epithelial cells.

M Pacurari1,2, I May3, P B Tchounwou1,2.   

Abstract

Multiwalled carbon nanotubes (MWCNT) have been shown to induce lung fibrosis in animal models, however the underlying molecular factors/mechanisms are still unclear. In this study, we investigated the effects of lipopolysaccharide (LPS), MWCNT, and the combination of LPS and MWCNT on the expression of matrix metalloproteinase-9 and metalloproteinase-12 (MMP-9, MMP-12), collagen 3A1 (Col3A1), and transforming growth factor beta (TGFβ) in alveolar epithelial A549 cells. MMPs are proteinases that degrade extracellular matrix and play a role in lung fibrosis. A549 cells were exposed to LPS (1 ng/mL), MWCNT (20 μg/mL), and the combination and analyzed for paracellular permeability, TGFβ, Col3A1, MMP-9, MMP-12, NF-κB activation, and cell migration by real-time PCR and immunofluorescence. LPS, the combination of LPS and MWCNT, and MWCNT only at the highest tested dose induced blue dextran extravasation. LPS and MWCNT increased the expression of TGFβ and its downstream target gene Col3A, and MMP-9 and MMP-12 mRNA. MWCNT potently induced cell migration toward wound healing, whereas LPS slightly induced cell migration. Both, LPS and MWCNT, induced NF-κB nuclear translocation. Our results indicate that MWCNT activated alveolar epithelial cells to promote fibrogenesis, and that LPS differentially primes molecular factors involved in lung remodeling. These findings suggest a role of alveolar epithelial cells in fibrogenesis and also may aid in the design and development of tests for screening of fibrogenic agents.
© 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 445-455, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ECM; LPS; MMP-12; MMP-9; MWCNT; NF-κB; TGFβ; alveolar epithelial cells; cell migration; collagen

Mesh:

Substances:

Year:  2016        PMID: 26880698      PMCID: PMC4987265          DOI: 10.1002/tox.22248

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  63 in total

1.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Authors:  T Hayashi; W G Stetler-Stevenson; M V Fleming; N Fishback; M N Koss; L A Liotta; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

2.  Multiwall carbon nanotubes directly promote fibroblast-myofibroblast and epithelial-mesenchymal transitions through the activation of the TGF-β/Smad signaling pathway.

Authors:  Peng Wang; Yue Wang; Xin Nie; Céline Braïni; Ru Bai; Chunying Chen
Journal:  Small       Date:  2014-09-25       Impact factor: 13.281

3.  Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.

Authors:  Marwa F Abd El-Fatah; Mohamed A Ghazy; Mohamed S Mostafa; May M El-Attar; Ahmed Osman
Journal:  Biochem Cell Biol       Date:  2015-07-20       Impact factor: 3.626

4.  Matrix metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein regulates cell migration, invasion, and adhesion.

Authors:  Yeon Hyang Kim; Hyung-Joo Kwon; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

5.  LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.

Authors:  Ja Eun Kim; Hong Sook Kim; Yong Jae Shin; Chang Seok Lee; Cheolhee Won; Sin Ae Lee; Jung Weon Lee; Youngsoo Kim; Jae Seung Kang; Sang Kyu Ye; Myung Hee Chung
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

6.  STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.

Authors:  Mesias Pedroza; Thuy T Le; Katherine Lewis; Harry Karmouty-Quintana; Sarah To; Anuh T George; Michael R Blackburn; David J Tweardy; Sandeep K Agarwal
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

7.  Human bronchial epithelial cells express and secrete MMP-12.

Authors:  Mark C Lavigne; Paresh Thakker; Jason Gunn; Anthony Wong; Joy S Miyashiro; Aeona M Wasserman; Shui-Qing Wei; Jeffrey W Pelker; Michiko Kobayashi; Michael J Eppihimer
Journal:  Biochem Biophys Res Commun       Date:  2004-11-12       Impact factor: 3.575

8.  Inhibition of human osteosarcoma cell migration and invasion by a gene silencer, pyrrole-imidazole polyamide, targeted at the human MMP9 NF-κB binding site.

Authors:  Toshio Kojima; Xiaofei Wang; Kyoko Fujiwara; Shunzo Osaka; Yukihiro Yoshida; Eiji Osaka; Masashi Taniguchi; Takahiro Ueno; Noboru Fukuda; Masayoshi Soma; Yasuaki Tokuhashi; Hiroki Nagase
Journal:  Biol Pharm Bull       Date:  2014       Impact factor: 2.233

9.  Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells.

Authors:  Brandi N Snyder-Talkington; Diane Schwegler-Berry; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  Part Fibre Toxicol       Date:  2013-08-01       Impact factor: 9.400

10.  Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes.

Authors:  Robert R Mercer; James F Scabilloni; Ann F Hubbs; Lori A Battelli; Walter McKinney; Sherri Friend; Michael G Wolfarth; Michael Andrew; Vincent Castranova; Dale W Porter
Journal:  Part Fibre Toxicol       Date:  2013-07-30       Impact factor: 9.400

View more
  2 in total

1.  Thrombospondin-1 and microRNA-1 expression in response to multiwalled carbon nanotubes in alveolar epithelial cells.

Authors:  M Pacurari; R Kafoury; T Turner; S Taylor; P B Tchounwou
Journal:  Environ Toxicol       Date:  2017-01-27       Impact factor: 4.119

2.  Different Cellular Response of Human Mesothelial Cell MeT-5A to Short-Term and Long-Term Multiwalled Carbon Nanotubes Exposure.

Authors:  Li Ju; Wei Wu; Min Yu; Jianlin Lou; Hao Wu; Xianhong Yin; Zhenyu Jia; Yun Xiao; Lijin Zhu; Jun Yang
Journal:  Biomed Res Int       Date:  2017-08-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.